Skip to main content
Free for a limited time Dementia Review

Biomarkers for dementia with Lewy bodies

DLB remains underdiagnosed due to its clinical and pathological heterogeneity, but emerging diagnostic and prognostic biomarkers could herald a new age of precision medicine.

Reducing relapse risk in Sydenham chorea

14-05-2024 Post-Infection Chorea News

Treating patients with Sydenham chorea with antibiotics, corticosteroids, or sodium valproate reduces the risk of relapse.

Hypotensive twilight zone in Parkinson’s disease

Free for a limited time Parkinson's Disease Case Study

Almost daily episodes of reduced responsiveness lasting up to an hour, with the patient slumped back in a chair but staying upright, indicated an under-recognised presentation of orthostatic hypertension.

Antipsychotic use in dementia has broad adverse outcomes

10-05-2024 Dementia News

Antipsychotic treatment of behavioral and psychological symptoms in patients with dementia is known to increase risk of stroke and death, but new findings indicate a broader range of adverse outcomes.

CGRP-targeting therapy for migraine

Free for a limited time Migraine Review

Calcitonin gene-related peptide (CGRP)-targeting agents are potential candidates for disease-modifying migraine therapy, but most studies have focused on efficacy. What are the long-term outcomes after discontinuation?

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on sleep in brain health

Live event concluded

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.

On-demand video coming soon

Dr. Rolf Fronczek
Dr. Renata Riha
Dr. Sven Rupprecht
Developed by: Springer Medicine

Hypotensive twilight zone in Parkinson’s disease

Free for a limited time Parkinson's Disease Case Study

Almost daily episodes of reduced responsiveness lasting up to an hour, with the patient slumped back in a chair but staying upright, indicated an under-recognised presentation of orthostatic hypertension.

Extensive neurogenic heterotopic ossification

Open Access Pain Due to Spasticity Case Study

After TBI, 10–20% of patients go on to develop progressive periarticular lamellar bone formation in extraskeletal tissues. This rare case involved significant pain and impaired motion in all four limbs.

CHANTER syndrome from fentanyl exposure in a young child

Open Access Cerebral Edema Case Study

Cerebellar, hippocampal, and basal nuclei transient edema with restricted diffusion (CHANTER) syndrome is a rare disorder associated with opioid neurotoxicity and almost exclusively seen in adults.

Current Reviews

Sublingual apomorphine in the treatment of Parkinson’s disease

Levodopa Neurology and Preclinical Neurological Studies - Review Article

Advanced Parkinson´s disease (PD) is often complicated by fluctuations of disability depending on plasma levels of levodopa. For most patients OFF phases with worsening of tremor and immobility, but also pain, depression, autonomic symptoms are …

Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review

Progressive supranuclear palsy (PSP) is a neurodegenerative disorder resulting from the deposition of misfolded and neurotoxic forms of tau protein in specific areas of the midbrain, basal ganglia, and cortex. It is one of the most representative …

The Role of Astrocytes in Migraine with Cortical Spreading Depression: Protagonists or Bystanders? A Narrative Review

Open Access Migraine REVIEW

Cortical spreading depression (CSD) is a slow wave of cortical depolarization closely associated with migraines with an aura. Previously, it was thought that CSD depolarization was mainly driven by neurons, with characteristic changes in neuronal …

HMGB1: A New Target for Ischemic Stroke and Hemorrhagic Transformation

Open Access Stroke Review

Stroke in China is distinguished by its high rates of morbidity, recurrence, disability, and mortality. The ultra-early administration of rtPA is essential for restoring perfusion in acute ischemic stroke, though it concurrently elevates the risk …

Alzheimer's Disease Independent Medical Education

Advances in Alzheimer's

Alzheimer's research and care is changing rapidly. Keep up with the latest developments from key international conferences, together with expert insights on how to integrate these advances into practice.

This content is intended for healthcare professionals outside of the UK.

Supported by: Lilly

Developed by: Springer Healthcare IME

News | Vodcasts | Podcasts (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)

Emerging biomarkers and disease-modifying therapies for Alzheimer’s disease promise significant changes in how the condition is diagnosed and managed.

Guide yourself through this transition with our education program, led by world renowned experts and covering the biggest international conferences.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME

Webinar (Link opens in a new window)

Interact with experts from established amyloidosis centers who can offer you specialized guidance to support your mission to set up a local center. Network with other HCPs in your locality to discuss region-specific challenges in establishing amyloidosis centers. 

Supported by:
  • AstraZeneca and Alexion
Developed by: Springer Healthcare IME

Webcast | eLearning | Infographic (Link opens in a new window)

PET biomarkers are fast becoming critical in the new era of disease modification for Alzheimer’s disease. Techniques around amyloid and tau require the expertise of nuclear medicine and radiology physicians to investigate and interpret PET scans in clinical settings. This program examines current and emerging biomarkers and assists in identifying patterns from different PET tracers in an interactive perceptual learning environment.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME
Alzheimer's Disease Independent Medical Education

Neuroimaging for Alzheimer’s disease: eLearning (Link opens in a new window)

Neuroimaging plays an increasingly critical role in clinical practice. PET Pearls is an interactive activity designed to improve your confidence and accuracy when interpreting imaging for early signs of cognitive impairment.

Supported by: Lilly

Developed by: Springer Healthcare IME

Further Reading

Clinical and kinematic characterization of parkinsonian soft signs in essential tremor

Open Access Tremor Neurology and Preclinical Neurological Studies - Original Article

Essential tremor (ET) is a common movement disorder characterized by bilateral action tremor of the upper limbs. The ET diagnosis requires no other signs of neurological disorders to be present (Bhatia et al. 2018 ). Recently, the term ET-plus has …

Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis

Open Access Multiple Sclerosis Original Research

Multiple sclerosis (MS) is a chronic immune-mediated inflammatory disease of the central nervous system, characterized by the involvement of white matter (WM) and gray matter (GM) since the early stages [ 1 ]. The hippocampus, a complex structure …

The Role of Astrocytes in Migraine with Cortical Spreading Depression: Protagonists or Bystanders? A Narrative Review

Open Access Migraine REVIEW

Cortical spreading depression (CSD) is a slow wave of cortical depolarization closely associated with migraines with an aura. Previously, it was thought that CSD depolarization was mainly driven by neurons, with characteristic changes in neuronal …

HMGB1: A New Target for Ischemic Stroke and Hemorrhagic Transformation

Open Access Stroke Review

Stroke in China is distinguished by its high rates of morbidity, recurrence, disability, and mortality. The ultra-early administration of rtPA is essential for restoring perfusion in acute ischemic stroke, though it concurrently elevates the risk …

Related topics

DLB remains underdiagnosed due to its clinical and pathological heterogeneity, but emerging diagnostic and prognostic biomarkers could herald a new age of precision medicine.

Read more

Children born to women with epilepsy who take topiramate when pregnant are not at increased risk for autism spectrum disorders, whereas there is an increased risk with valproate.

Read more